We are thrilled to have you on our site. If you enjoy the post you have just found kindly Share it with friends.
Today, Friday, the European Medicines Agency approved the use of a new anti-corona virus vaccine for an age group of children.
A source in the agency said that the authority, in charge of regulating medicines in the European Union, had approved the use of the “Bountec-Pfizer” vaccine for the age group of 12 to 15 years.
Thus, this vaccine becomes the first to get the green light to vaccinate children against this epidemic in the European Union.
“As expected, the European Medicines Agency’s Human Medicines Committee has approved the use of the Pfizer-Biontech vaccine for children and adolescents between the ages of 12 and 15,” Marco Cavalieri, director of vaccination strategy at the agency, told reporters.
He added that clinical test data “really shows that the vaccine significantly protects” younger groups.
The use of the vaccine, which is produced by the US giant “Pfizer” in conjunction with the German “Biontech”, has so far been limited to people over the age of 16 in the 27 European Union countries.
“Pfizer” and its partner “Biontech” confirmed last March that their two-dose vaccine proved to be safe and effective during a test conducted on 2,260 people aged 12-15 years.
Emir Cook, director of the European Medicines Agency, told European newspapers on May 11 that the agency had received Bionic-Pfizer data and “we have promised data from clinical tests and the study that was done in Canada within the next two weeks, and we will speed up our assessment.”
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of Algulf.net and Algulf.net does not assume any responsibility or liability for the same.